Family-Owned Kent Pharmaceutical Holdings Sold in $77 Million Deal
Published: Jan 14, 2013
A family-owned drugs firm has been sold in a £58 million deal. Kent Pharmaceuticals Holdings Limited (KPHL), based in Orbital Park, Ashford, is now part of DCC Healthcare after its acquisition by its DCC Vital subsidiary. Kent law firm Brachers played a key role the transaction, advising the majority shareholders in one of the largest deals handled by the firm in 2012. Kent Pharmaceuticals is a family business set up in the early 1980s. It went on to become Britain’s largest independent generic pharmaceuticals manufacturer and leading wholesaler. It is involved in the development, manufacture, sales, marketing and distribution of generic products for the British, Irish and international markets. It offers more than 100 own label products, with a manufacturing plant in Ireland supplying the UK with some 60% of the total penicillin antibiotics sold. DCC Vital, a healthcare services business, provides sales, marketing and distribution services in Ireland and Britain to healthcare providers, medical and pharmaceutical brand owners and manufacturers. DCC Plc is based in Ireland with a workforce of 9,000. DCC plans to combine the Kent business to create a pharmaceuticals business with combined turnover of around £123 million. A spokesman said there were plans for expansion which could involve more jobs.